CEO, Sandstone Diagnostics, Inc.
Karen Drexler has spent the last 25 years co-founding and building medical device companies, mainly in the diagnostics space. She is the CEO of Sandstone Diagnostics, Inc., a medtech company that develops instruments and consumables for point-of-care medical testing. Karen was President and CEO of Amira Medical, a glucose monitoring company that was sold to Roche in 2001. She is currently an active board member with Hygieia, Inc., Ann Arbor, MI (Chairperson of the Board – diabetes management), diaDexus, South San Francisco, CA (Board member, chair of the Compensation Committee – cardiovascular risk markers), Naia Health, A Springboard Company, Palo Alto, CA (Board member – innovative, connected breast pump) Sandstone Diagnostics, Livermore, CA (Board member – OTC male fertility tests) and the Keller Center for Innovation in Engineering Education, Princeton University. Karen also acts as a senior strategic advisor for several other early stage companies. The holder of 11 issued patents, Karen received her MBA from the Graduate School of Business, Stanford University and her BSE in Chemical Engineering from Princeton University.